A detailed history of Versor Investments LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Versor Investments LP holds 12,400 shares of TXG stock, worth $181,908. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,400
Previous 13,200 6.06%
Holding current value
$181,908
Previous $256,000 8.98%
% of portfolio
0.04%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$15.71 - $23.49 $12,568 - $18,792
-800 Reduced 6.06%
12,400 $279,000
Q2 2024

Aug 01, 2024

BUY
$19.45 - $37.37 $7,138 - $13,714
367 Added 2.86%
13,200 $256,000
Q1 2024

May 13, 2024

BUY
$36.08 - $54.3 $463,014 - $696,831
12,833 New
12,833 $481,000
Q3 2023

Nov 06, 2023

SELL
$40.86 - $62.98 $133,857 - $206,322
-3,276 Reduced 32.89%
6,683 $275,000
Q2 2023

Aug 07, 2023

BUY
$50.96 - $58.72 $507,510 - $584,792
9,959 New
9,959 $556,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.39B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.